Limbic-midbrain interactions in defense and emotional arousal
边缘系统-中脑在防御和情绪唤醒中的相互作用
基本信息
- 批准号:9896581
- 负责人:
- 金额:$ 70.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-03 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcousticsAcuteAgonistAmygdaloid structureAnatomyAnimal ModelAnimalsAnxietyAnxiety DisordersArchitectureArousalAttentionAttenuatedBehaviorBehavioralBicucullineBlood PressureBrainCell NucleusDataDeep Brain StimulationDiseaseDisinhibitionDissectionDissociationElementsEmotionalFrightGABA AntagonistsGoalsHeart RateHumanImpairmentIndividualInfusion proceduresKnowledgeLeadMagnetic Resonance ImagingMediatingMicroinjectionsMidbrain structureModelingMotorMuscimolNational Institute of Mental HealthPathologyPathway interactionsPatientsPatternPharmacologyPopulationPrimatesProsencephalonPsychiatryPulvinar structureRefractoryRegulationResearchResearch Domain CriteriaRodentRodent ModelRoleRouteScienceSeriesSideSiteSnakesSocial BehaviorSocial FunctioningSocial InteractionStimulusStructureSubstantia nigra structureSymptomsTechniquesTechnologyTestingTherapeutic InterventionValidationVisualWithdrawalanatomical tracinganxiety treatmentbasebehavioral phenotypingbehavioral responsedefense responsedesigner receptors exclusively activated by designer drugsdisabling symptomeffective therapyemotion dysregulationemotional reactionexperimental studyfrontal lobehindbraininterestmidbrain central gray substanceneural circuitneuroimagingnonhuman primatenovelrelating to nervous systemresponseside effectsocialsuperior colliculus Corpora quadrigeminatreatment of anxiety disordersvocalization
项目摘要
Exaggerated emotional reactivity, impaired social function, aberrant regulation of defense behaviors, and
autonomic dysregulation are a constellation of debilitating symptoms that are present in a range of anxiety
disorders. Anxiety disorders, as a group, impact about 20% of the US population and treatments for anxiety
disorders are only partially effective and often associated with side effects. While most attention has focused
on fronto-limbic circuitry, a current gap in knowledge is the contribution of hindbrain circuits. A second major
gap is how hindbrain and forebrain sites interact. Moreover, the vast majority of circuit-level characterization
has occurred in rodent models, which leads to the third major gap in knowledge: the functional organization of
these circuits in non-human primates. Indeed, as evidenced by findings in our lab and by others, the primate
brain is organized in often surprisingly different manners than the rodent brain. Thus, understanding the
organization of these circuits in the primate brain is essential to understanding the organization of the human
brain. We have previously found that acute disinhibition of the deep layers of the superior colliculus (DLSC), a
midbrain structure, by focal infusions of the GABAA antagonist, bicuculline, precipitated a state of exaggerated
defensive and emotional reactivity (DER). Concurrent inhibition of the basolateral amygdala (BLA) reduced
some but not all of the defense responses, suggesting differential circuitry underlying individual components of
the defensive response. In this application, we propose to determine the circuit architecture by which hindbrain
(DLSC, PAG) and forebrain (BLA, central nucleus of the amygdala, pulvinar) regions interact to produce
defensive emotional reactions, unconditioned fear, dysregulation of social behavior, and autonomic arousal. In
the two proposed specific aims, we will test the hypotheses that induced inhibition of the limbic components will
attenuate the DER evoked from the midbrain structures and that induced inhibition of midbrain structures will
attenuate the DER evoked from the forebrain. Using MRI-guided intracerebral microinfusions, we will
transiently activate and inactivate components of this network and determine the resulting impact on anxiety-
relevant behavioral responses. Following these experiments, we will employ anatomical tracer techniques to
characterize projection pathways of interest. We will also perform validation experiments using Designer
Receptors Exclusively Activated by Designer Drugs (DREADDs), which have grown in use in rodents, but
remain rarely used in primates, to help move this translational technology forward. We expect that our data will
have implications for understanding the pathology of anxiety disorders.
夸大的情绪反应,受损的社会功能,防御行为的异常调节,
自主神经失调是一系列使人衰弱的症状,存在于一系列焦虑症中
紊乱焦虑症,作为一个群体,影响约20%的美国人口和治疗焦虑
这些疾病仅部分有效,并且通常伴随副作用。虽然大多数注意力都集中在
关于额边缘电路,目前的知识差距是后脑电路的贡献。第二主
间隙是后脑和前脑部位如何相互作用的。此外,绝大多数电路级特性
在啮齿动物模型中发生,这导致了知识的第三个主要空白:
在非人类的灵长类动物身上发现了这些回路。事实上,正如我们实验室和其他实验室的发现所证明的那样,
大脑的组织方式往往与啮齿动物的大脑惊人地不同。因此,理解
灵长类动物大脑中这些回路的组织对于理解人类大脑的组织至关重要。
个脑袋我们以前发现,急性去抑制的深层上级丘(DLSC),
中脑结构,由GABAA拮抗剂,荷包牡丹碱局灶性输注,沉淀的状态夸大
防御和情绪反应(Defense and Emotional Reaction,DER)同时抑制基底外侧杏仁核(BLA)减少
一些但不是所有的防御反应,表明差异电路的个别组成部分,
防御性反应。在本应用中,我们建议确定后脑的电路结构
(DLSC,PAG)和前脑(BLA,杏仁核中央核,枕)区域相互作用以产生
防御性情绪反应、无条件恐惧、社会行为失调和自主觉醒。在
这两个提出的具体目标,我们将测试的假设,诱导抑制的边缘成分将
减弱从中脑结构诱发的DER,并且中脑结构的诱导抑制将
减弱前脑诱发的DER。使用MRI引导的脑内微量输注,
瞬时激活和激活这个网络的组成部分,并确定对焦虑的影响-
相关的行为反应。在这些实验之后,我们将采用解剖示踪技术,
表征感兴趣的投射路径。我们还将使用Designer执行验证实验
受体专门由设计药物激活(DREADDs),这已经在啮齿动物中使用,但
仍然很少用于灵长类动物,以帮助推动这种转化技术的发展。我们希望我们的数据
对理解焦虑症的病理学有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Alexander Forcelli其他文献
Patrick Alexander Forcelli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick Alexander Forcelli', 18)}}的其他基金
Pharmacological Sciences Training Program (PSTP)
药理科学培训计划(PSTP)
- 批准号:
10491483 - 财政年份:2022
- 资助金额:
$ 70.74万 - 项目类别:
Pharmacological Sciences Training Program (PSTP)
药理科学培训计划(PSTP)
- 批准号:
10652636 - 财政年份:2022
- 资助金额:
$ 70.74万 - 项目类别:
Targeting cellular senescence to prevent epileptogenesis
针对细胞衰老预防癫痫发生
- 批准号:
10362263 - 财政年份:2022
- 资助金额:
$ 70.74万 - 项目类别:
Limbic-midbrain interactions in defense and emotional arousal
边缘系统-中脑在防御和情绪唤醒中的相互作用
- 批准号:
10312050 - 财政年份:2020
- 资助金额:
$ 70.74万 - 项目类别:
Limbic-midbrain interactions in defense and emotional arousal
边缘系统-中脑在防御和情绪唤醒中的相互作用
- 批准号:
10094260 - 财政年份:2020
- 资助金额:
$ 70.74万 - 项目类别:
Limbic-midbrain interactions in defense and emotional arousal
边缘系统-中脑在防御和情绪唤醒中的相互作用
- 批准号:
10531250 - 财政年份:2020
- 资助金额:
$ 70.74万 - 项目类别:
Structural and functional sequelae of neonatal anticonvulsant exposure: drug-seizure interactions
新生儿抗惊厥药物暴露的结构和功能后遗症:药物与癫痫发作的相互作用
- 批准号:
10454335 - 财政年份:2018
- 资助金额:
$ 70.74万 - 项目类别:
Structural and functional sequelae of neonatal anticonvulsant exposure: drug-seizure interactions
新生儿抗惊厥药物暴露的结构和功能后遗症:药物与癫痫发作的相互作用
- 批准号:
10453914 - 财政年份:2018
- 资助金额:
$ 70.74万 - 项目类别:
Structural and functional sequelae of neonatal anticonvulsant exposure: drug-seizure interactions
新生儿抗惊厥药物暴露的结构和功能后遗症:药物与癫痫发作的相互作用
- 批准号:
10654181 - 财政年份:2018
- 资助金额:
$ 70.74万 - 项目类别:
Structural and functional sequelae of neonatal anticonvulsant exposure: drug-seizure interactions
新生儿抗惊厥药物暴露的结构和功能后遗症:药物与癫痫发作的相互作用
- 批准号:
10085123 - 财政年份:2018
- 资助金额:
$ 70.74万 - 项目类别:
相似海外基金
Elucidation of acute poisoning mechanism due to abuse of CB1 receptor agonist.
阐明滥用 CB1 受体激动剂引起的急性中毒机制。
- 批准号:
21K17323 - 财政年份:2021
- 资助金额:
$ 70.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of acute poisoning mechanism due to abuse of CB1 receptor agonist.
阐明滥用 CB1 受体激动剂引起的急性中毒机制。
- 批准号:
19K19485 - 财政年份:2019
- 资助金额:
$ 70.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Tissue repair effect in acute myocardial infarction through mobilization of endogenous Muse cells by sphingosine-1-phosphate receptor 2 agonist
1-磷酸鞘氨醇受体2激动剂动员内源性Muse细胞对急性心肌梗死的组织修复作用
- 批准号:
18K15843 - 财政年份:2018
- 资助金额:
$ 70.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6115624 - 财政年份:1998
- 资助金额:
$ 70.74万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6219539 - 财政年份:1998
- 资助金额:
$ 70.74万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6276858 - 财政年份:1997
- 资助金额:
$ 70.74万 - 项目类别:
ACUTE CHRONIC HORMONAL CHANGES WITH LHRH-AGONIST THERAPY
LHRH 激动剂治疗引起的急性慢性荷尔蒙变化
- 批准号:
6250152 - 财政年份:1997
- 资助金额:
$ 70.74万 - 项目类别:
ACUTE CHRONIC HORMONAL CHANGES WITH LHRH-AGONIST THERAPY
LHRH 激动剂治疗引起的急性慢性荷尔蒙变化
- 批准号:
6279945 - 财政年份:1997
- 资助金额:
$ 70.74万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6246787 - 财政年份:1997
- 资助金额:
$ 70.74万 - 项目类别:
PSYCHOPHARMACOLOGY OF DA AGONIST CNS EFFECTS: ACUTE AND CHRONIC STUDIES
DA 激动剂中枢神经系统影响的精神药理学:急性和慢性研究
- 批准号:
3891471 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:














{{item.name}}会员




